Every material Form 8-K Butterfly Network, Inc. has filed with the SEC since August 11, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Butterfly Network reported third-quarter 2026 revenue of $32.6 million, up 52% from $21.5 million a year earlier, and a net loss of $12.8 million, down from $34.0 million. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, but its fourth-quarter revenue guidance of $31 million to $34 million implies about 3% growth at the midpoint.
Q3 2026 revenue was $32.6 million, up 52%; U.S. revenue rose 71% to $27.5 million while international revenue fell 5% to $5.1 million.
Q3 GAAP gross margin was 73.0%, compared with a negative 17.5% a year earlier, which included a $17.4 million inventory write-down.
Full-year 2026 revenue guidance was raised to $123 million to $126 million; adjusted EBITDA loss guidance is $12 million to $15 million.
Cash and cash equivalents were $122.3 million as of September 30, 2026, down from $150.5 million at December 31, 2025.
Butterfly Network, Inc. said its Board appointed semiconductor executive Michael Noonen as a director, effective October 9, 2026, and expanded the board to seven members. Noonen will also serve on the Compensation and Technology Committees, and he receives standard nonemployee director compensation, including restricted stock units valued at $300,000. The board appointment adds a new director with semiconductor leadership experience, but the filing reports no change in financial results.
Michael (Mike) Noonen appointed to the Board effective October 9, 2026; board size increased to seven directors
Noonen joins the Compensation Committee and Technology Committee
Initial RSU grant with a fair market value of $300,000, vesting in equal annual installments over three years
Board determined Noonen is independent under NYSE listing standards
Dr. Erica Schwartz, a Butterfly Network director since 2021, left the board automatically when the U.S. Senate confirmed her as Director of the Centers for Disease Control and Prevention on August 5, 2026. The company said her departure was not the result of any disagreement over its operations, policies, or practices, so the change is a routine board transition for shareholders.
Schwartz's resignation was announced earlier in a May 8, 2026 Form 8-K and took effect automatically on her confirmation on August 5, 2026.
The company said the resignation was not due to any disagreement with Butterfly on its operations, policies, or practices.
CEO Joseph DeVivo praised Schwartz in a press release dated August 11, 2026 (Exhibit 99.1).
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Butterfly Network, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →